Skip to content

Diagnostic Value of Portable Ultrasound for Dyspneic Patient Support in the Emergency Department

Evaluation of the Diagnostic Value of Portable Ultrasound for Dyspneic Patient Support in the Emergency Department: a Randomized Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01818882
Acronym
VSCAN-DYSP
Enrollment
85
Registered
2013-03-27
Start date
2014-04-30
Completion date
2016-01-31
Last updated
2016-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspnea

Keywords

Vscan, portable ultrasound, emergency care, emergency room

Brief summary

The main objective of our study is to compare the effects of two care strategies for dyspneic patients on the length of hospital stay: (1) standard care (=contextual analysis + conventional clinical chest radiography) versus (2) standard care + pleuropulmonary ultrasound.

Detailed description

The secondary objectives of this study are to assess the following for both arms: A-fatality rate, B-degree of concordance between the diagnosis orientation in the emergency department and final diagnosis determined by an expert committee using patient records one month later (blind evaluation by a panel of experts) C-clinical improvement between early emergency care and later care outside the emergency department (clinical parameters = blood gases and other biological parameters) D-imaging parameters.

Interventions

OTHERStandard care

Standard care for dyspneic patients including contextual analysis, conventional clinical exam and a chest X-Ray.

DEVICEVscan portable ultrasound device (GE Healthcare, Wauwatosa, WI)

Standard care (as described for the other intervention) + pleuropulmonary ultrasound using the Vscan portable ultrasound device (GE Healthcare, Wauwatosa, WI).

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * Patient consulting in the emergency department for dyspnea

Exclusion criteria

* The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection, under tutorship or curatorship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * The patient cannot read French * The patient is pregnant, parturient, or breastfeeding

Design outcomes

Primary

MeasureTime frame
Length of hospital stay in days1 month

Secondary

MeasureTime frame
Diagnosis in the emergency roomupon discharge from the emergency department (max 1 month)
Diagnosis given by expert committee based on patient file1 month
Glasgow scaleBaseline, day 0
Heart ratebaseline, day 0
Respiratory ratebaseline, day 0
Systolic blood pressurebaseline, day 0
Diastolic blood pressurebaseline, day 0
Temperaturebaseline, day 0
blood pHbaseline, day 0
CO2 arterial pressurebaseline, day 0
O2 arterial pressurebaseline, day 0
O2 saturationbaseline, day 0
Alkaline reservebaseline, day 0
white blood cell countbaseline, day 0
C-reactive proteinbaseline, day 0
Brain Natriuretic Peptidebaseline, day 0
Patient deceased? yes/no1 month
Pulmonary x-ray, yes/nobaseline, day 0
right alveolar opacities on x-ray, yes/nobaseline, day 0
left alveolar opacities on x-ray, yes/nobaseline, day 0
right parenchymal origin on x-ray, yes/nobaseline, day 0
left parenchymal origin on x-ray, yes/nobaseline, day 0
right pleural effusion on x-ray, yes/nobaseline, day 0
left pleural effusion on x-ray, yes/nobaseline, day 0
pleuropulmonary ultrasound, yes/nobaseline, day 0
right alveolar-interstitial syndrome on ultrasound, yes/nobaseline, day 0
left alveolar-interstitial syndrome on ultrasound, yes/nobaseline, day 0
right lung consolidation on ultrasound, yes/nobaseline, day 0
left lung consolidation on ultrasound, yes/nobaseline, day 0
right pleural effusion on ultrasound, yes/nobaseline, day 0
left pleural effusion on ultrasound, yes/nobaseline, day 0
right pneumothorax on ultrasound, yes/nobaseline, day 0
left pneumothorax on ultrasound, yes/nobaseline, day 0
hemoglobinbaseline, day 0

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026